NEWS

:Home Video: TGR Liguria – ASG Superconductors: a new approach to the future of cancer treatment
Published On: 27-04-2021Categories: In Evidence, Press Clipping

Towards live imaging in proton therapy
ASG Superconductors with HZDR combine magnetic resonance imaging with particle beams.

ASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world’s first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy, combining a rotating open MRI device for the LINAC-MR system Alberta Health Services, with an actively scanned clinical-akin proton beam at OncoRay, the Dresden-based National Center for Radiation Research in Oncology. The rotating MRI device is produced by ASG Superconductors, using the MROpen Evo technology-based helium-free superconducting MgB2 magnet. Real-time MRI would make it possible to synchronize the proton beam to tumor motion during radiation dose delivery. So far, this has been impossible and therefore was a limiting factor for treating moving tumors with this promising cancer therapy.

Video

NEWS

DISCOVER MORE

BE OPEN.

Discover MROpen EVO

STRESS FREE MRI.

Discover the best MRI experience

DON’T GUESS. SEE.

Discover a new clinical approach

STAND OUT.

Make your MRI center unique

LET IDEAS BE FEASIBLE.

Discover research applications
Go to Top